NEWS: NOVEMBER 2005

-11/30/2005-

Press Release: The Starfish from Radleys Discovery Technologies is a heating and stirring experiment work station designed to provide a safe, clean and more productive alternative to using oil baths and heating mantles. To read press release click here.

XenoPort Inc. and Astellas Pharma Inc. form alliance to develop and commercialize XenoPort's drug candidate XP13512. To read article click here.

BioCryst Pharmaceuticals Inc. and Roche form research collaboration on BioCryst's drug candidate BCX-4208 for the prevention of acute rejection in transplantation and for the treatment of autoimmune diseases. To read article click here.

Surface Logix initiates Phase IIa clinical trials of oral PDE5 inhibitor SLx-2101 for the treatment of vascular and cardiovascular diseases. To read article click here.

Schering AG initiates 3 Phase II clinical trials of its fully synthetic epothilone ZK-EPO for the treatment of several types of cancers. To read article click here.

-11/29/2005-

Press Release: Velocity11 has announced a new high-speed, precision liquid handling platform - the Bravo™. To read press release click here.

Discovery Partners International Inc. to close its South San Francisco facility. To read article click here.

Seattle Genetics Inc. begins clinical trials of SGN-40 for chronic lymphocytic leukemia treatment. To read article click here.

-11/28/2005-

Press Release: A new independently researched and written technical report, available from Radleys Discovery Technologies, concludes that the Metz Syn10 reaction station shows great potential for applications in microbiological research. To read press release click here.

Press Release: The Mat Capper from Porvair Sciences Ltd is an easy-to-use plate sealer for laboratories looking to maintain the integrity of microplate samples that may come to them in a variety of formats. To read press release click here.

Enzon Pharmaceuticals Inc. and Micromet AG terminate research collaboration. To read article click here.

Coley Pharmaceutical Group Inc. begins two Phase III clinical trials of PF-3512676 (CPG 7909, formerly ProMune™) for non-small cell lung cancer (NSCLC). To read article click here.

Rigel Pharmaceuticals Inc. publishes in Molecular Biology of the Cell the role of a E3 ubiquitin ligase known as UHRF1 in the regulation of cellular proliferation and cellular repair. To read article click here.

-11/22/2005-

Telik Inc. to provide a corporate update at the Lazard Capital Markets Life Sciences Conference in New York City on November 30, 2005 at 9:30 am Eastern time. To read article click here.

Cell Genesys Inc. sells its San Diego manufacturing operation to Genzyme Corp. for $3.2 million in cash. To read article click here.

-11/21/2005-

Press Release: Available from Velocity11 the VPrep pipetting station is the fastest precision pipettor on the market. To read press release click here.

Curis Inc. and Wyeth extend their collaboration on neurological disorders treatment. To read article click here.

Incyte Corp. and Pfizer Inc. form inflamation research collaboration on CCR2 antagonists. To read article click here.

-11/17/2005-

Biogen Idec Inc. discovers new receptor key in Parkinson's disease. To read article click here.

Seattle Genetics Inc. begins Phase I clinical trials of SGN-33 for acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) treatment. To read article click here.

Tibotec Pharmaceuticals Ltd. begins Phase III clinical trials of its non-nucleoside reverse transcriptase TMC125. To read article click here.

-11/16/2005-

Press Release: Genevac, specialists in solvent removal, have announced a comprehensive new range of sample accessories designed to fit in both their EZ-2 and HT-4 centrifugal evaporators. To read press release click here.

Kinexus Bioinformatics Corp. launches the KiNET Functional Proteomics Database. To read article click here.

-11/15/2005-

Sunesis Pharmaceuticals Inc. begins Phase I clinical trials of SNS-595 for leukemia treatment. To read article click here.

-11/14/2005-

Press Release: ChemAxon supports open source chemical inventory application for universities. To read press release click here.

Press Release: Porvair Sciences, specialists in application specific microplate technology, have announced a new technical report that demonstrates the importance of high quality raw material selection for the manufacture of deep well microplates. To read press release click here.

Press Release: The VACUSAFE comfort from INTEGRA Biosciences is a highly safe vacuum system that has been specifically developed for easy and rapid aspiration of biohazardous liquids. To read press release click here.

Discovery Partners International Inc.'s CEO Riccardo Pigliucci resigns. To read article click here.

TorreyPines Therapeutics Inc. begisn Phase I clinical trials of NGX424 for pain. To read article click here.

-11/11/2005-

Keryx Biopharmaceuticals Inc. announces positive results from Phase II clinical trials of KRX-101 (sulodexide gelcaps) for Diabetic Nephropathy treatment. To read article click here.

Telik Inc. to provide a corporate update at the CSFB Annual Healthcare Conference in Phoenix, Arizona on November 16, 2005 at 11:30 am Eastern time. To read article click here.

Advancis Pharmaceutical Corp. initates Phase III clinical trials of Amoxicillin PULSYS for adults and adolescents with pharyngitis/tonsillitis. To read article click here.

-11/10/2005-

ImClone CEO resigns. To read article click here.

FDA approves Enzon Pharmaceuticals Inc.'s IV formulation of Oncaspar for treatment of leukemia in children. To read article click here.

PolyMedix Inc. appoints Timothy Henkel, M.D., Ph.D. as Vice President, Drug Development and Chief Medical Officer. To read article click here.

-11/09/2005-

Amgen Inc. sues Roche Holding AG for patent infringment on Epogen patents. To read article click here.

Stem Cell Therapeutics Corp. and Medicon A/S to initiate Phase I clinical trials of SCT's NTx™-265 for stroke treatment. To read article click here.

-11/08/2005-

Varian Inc. acquires Polymer Laboratories Ltd. To read article click here.

Sigma-Aldrich Corp. names Jai Nagarkatti as President and CEO effective January 1, 2006. To read article click here.

Telik Inc. announces third quarter 2005 financial results. To read article click here.

Astellas Pharma Inc. selects additional validated targets for drug screening and development from collaboration with Metabolex Inc. To read article click here.

Amphora Discovery Corp. to present at the AACR-NCI-EORTC International Conference results of its AKT and Target Tyrosine Kinase programs. To read article click here.

-11/07/2005-

Press Release: Available from Genevac heat transfer plates in conjunction with centrifugal evaporation provides a highly productive and sample safe solution for removal of solvent from microplate samples. To read press release click here.

Theravance Inc. and Astellas Pharma Inc. form collaboration on Theravance's antibiotic drug candiate Telavancin. To read article click here.

Sunesis Pharmaceuticals Inc. to present at the AACR-NCI-EORTC International Conference results of its SNS-595 and Kinase Inhibitor programs. To read article click here.

ChemDiv Inc. and ProQinase GmbH form partnership for the discovery and preclinical development of new kinase inhibitors. To read article click here.

Isis Pharmaceuticals Inc. begins Phase II clinical trials of ISIS 301012 in combination with a statin in patients with high cholesterol. To read article click here.

-11/04/2005-

Memory Pharmaceuticals Corp. initiates Phase 2a clinical trials of MEM 1003 for moderate Alzheimer's disease treatment. To read article click here.

-11/03/2005-

FDA approves Tarceva for pancreatic cancer treatment. To read article click here.

Abgenix Inc. and Amgen Inc.'s colon anti-cancer drug Panitumumab gives better than expected results in clinical trials. To read article click here.

Array BioPharma Inc. and Ono Pharmaceutical Co. Ltd. form drug discovery kinase research collaboration. To read article click here.

Millennium Pharmaceuticals Inc. begins Phase I clinical trials of highly selective Aurora kinase inhibitor MLN8054. To read article click here.

-11/02/2005-

Biolex Therapeutics initiates Phase I clinical trials of Locteron™ for Hepatitis C treatment. To read article click here.

-11/01/2005-

Alnylam Pharmaceuticals Inc. submits investigational new drug (IND) application for ALN-RSV01 to the FDA for respiratory syncytial virus (RSV) infection. To read article click here.

Quest Diagnostics Inc. acquires LabOne Inc. To read article click here.